Cargando…

Effectiveness of the Novel Anti-TB Bedaquiline against Drug-Resistant TB in Africa: A Systematic Review of the Literature

Background: In 2018, an estimated 10.0 million people contracted tuberculosis (TB), and 1.5 million died from it, including 1.25 million HIV-negative persons and 251,000 HIV-associated TB fatalities. Drug-resistant tuberculosis (DR-TB) is an important contributor to global TB mortality. Multi-drug-r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Traoré, Afsatou Ndama, Rikhotso, Mpumelelo Casper, Banda, Ntshuxeko Thelma, Mashilo, Maphepele Sara, Ngandu, Jean Pierre Kabue, Mavumengwana, Vuyo, Loxton, Andre G., Kinnear, Craig, Potgieter, Natasha, Heysell, Scott, Warren, Rob
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229213/ https://www.ncbi.nlm.nih.gov/pubmed/35745490 http://dx.doi.org/10.3390/pathogens11060636

Ejemplares similares

Prevalence of Human Bocavirus in Africa and Other Developing Countries between 2005 and 2016: A Potential Emerging Viral Pathogen for Diarrhea
por: Rikhotso, Mpumelelo Casper, et al.
Publicado: (2018)

Predominance of Human Bocavirus Genotype 1 and 3 in Outpatient Children with Diarrhea from Rural Communities in South Africa, 2017–2018
por: Rikhotso, Mpumelelo Casper, et al.
Publicado: (2020)

Prevalence and Genetic Characterisation of Human Sapovirus from Children with Diarrhoea in the Rural Areas of Vhembe District, South Africa, 2017–2020
por: Magwalivha, Mpho, et al.
Publicado: (2021)

Partial Analysis of the Capsid Protein (VP1) of Human Sapovirus Isolated from Children with Diarrhoea in Rural Communities of South Africa
por: Magwalivha, Mpho, et al.
Publicado: (2022)

Isoniazid and Rifampicin Resistance-Conferring Mutations in Mycobacterium tuberculosis Isolates from South Africa
por: Traoré, Afsatou Ndama, et al.
Publicado: (2023)

Prevalence of Human Sapovirus in Low and Middle Income Countries
por: Magwalivha, Mpho, et al.
Publicado: (2018)

Human Astrovirus in Symptomatic and Asymptomatic Children: A Cross-Sectional Study on Hospitalized and Outpatients from Rural Communities of South Africa between 2017–2021
por: Khumela, Ronewa, et al.
Publicado: (2021)

Prevalence of Human Norovirus GII.4 Sydney 2012 [P31] between 2019 and 2021 among Young Children from Rural Communities in South Africa
por: Khumela, Ronewa, et al.
Publicado: (2023)

Prevalence and Antimicrobial Resistance Profile of Diarrheagenic Escherichia coli from Fomites in Rural Households in South Africa
por: Rakhalaru, Phathutshedzo, et al.
Publicado: (2023)

High Burden of Co-Infection with Multiple Enteric Pathogens in Children Suffering with Diarrhoea from Rural and Peri-Urban Communities in South Africa
por: Potgieter, Natasha, et al.
Publicado: (2023)

Norovirus-Associated Gastroenteritis Vesikari Score and Pre-Existing Salivary IgA in Young Children from Rural South Africa
por: Kabue, Jean-Pierre, et al.
Publicado: (2023)

Bedaquiline for multidrug-resistant TB in paediatric patients
por: Moodliar, R., et al.
Publicado: (2021)

The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens
por: Khan, Uzma, et al.
Publicado: (2019)

Prolonged use of bedaquiline in the treatment for MDR-TB in a child
por: Gubkina, Marina F., et al.
Publicado: (2021)

Addressing bedaquiline treatment interruptions in the treatment of drug-resistant TB
por: Kambili, C., et al.
Publicado: (2022)

Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort( )
por: Hewison, Catherine, et al.
Publicado: (2022)

Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts
por: Oelofse, S., et al.
Publicado: (2021)

Impact of Rv0678 mutations on patients with drug-resistant TB treated with bedaquiline
por: Kaniga, K., et al.
Publicado: (2022)

Correction to: Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort
Publicado: (2023)

Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB
por: Millard, James, et al.
Publicado: (2023)

Rifampicin and rifapentine significantly reduce concentrations of bedaquiline, a new anti-TB drug
por: Svensson, Elin M., et al.
Publicado: (2015)

Bedaquiline (BDQ) resistance in an adolescent with multidrug-resistant tuberculosis (MDR-TB): An alarm for pediatricians
por: Cesilia, Citra, et al.
Publicado: (2023)

Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): a 5-Year Prospective In Vitro Surveillance Study of Bedaquiline and Other Second-Line Drug Susceptibility Testing in MDR-TB Isolates
por: Kaniga, Koné, et al.
Publicado: (2022)

Modelling of mycobacterial load reveals bedaquiline’s exposure–response relationship in patients with drug-resistant TB
por: Svensson, Elin M, et al.
Publicado: (2017)

First experience of effectiveness and safety of bedaquiline for 18 months within an optimised regimen for XDR-TB
por: Lewis, Joseph M., et al.
Publicado: (2016)

Structure of the mycobacterial ATP synthase F(o) rotor ring in complex with the anti-TB drug bedaquiline
por: Preiss, Laura, et al.
Publicado: (2015)

Binding properties of the anti-TB drugs bedaquiline and TBAJ-876 to a mycobacterial F-ATP synthase
por: Krah, Alexander, et al.
Publicado: (2022)

Multidrug-Resistant TB in the Philippines: Authors' Reply
por: Tupasi, Thelma
Publicado: (2006)

Editorial: Antimicrobial resistance and one health: from culture to genomics
por: Abia, Akebe Luther King, et al.
Publicado: (2023)

Investigating Non-sterilizing Cure in TB Patients at the End of Successful Anti-TB Therapy
por: Beltran, Caroline G. G., et al.
Publicado: (2020)

TB Anywhere is TB Everywhere
por: Wortham, Jonathan M.
Publicado: (2018)

TB or not TB! That’s the question
por: Nugud, Ahmed, et al.
Publicado: (2019)

Interleukin 10 (IL-10) Production and Seroprevalence of Entamoeba histolytica Infection among HIV-Infected Patients in South Africa
por: Ngobeni, Renay, et al.
Publicado: (2022)

Use of a molecular bacterial load assay to distinguish between active TB and post-TB lung disease
por: Mbelele, P. M., et al.
Publicado: (2022)

Bacterial Contamination of Children’s Toys in Rural Day Care Centres and Households in South Africa
por: Ledwaba, Solanka Ellen, et al.
Publicado: (2019)

Neutrophils: Innate Effectors of TB Resistance?
por: Kroon, Elouise E., et al.
Publicado: (2018)

Human Enteric Pathogens in Eight Rivers Used as Rural Household Drinking Water Sources in the Northern Region of South Africa
por: Potgieter, Natasha, et al.
Publicado: (2020)

The African Wastewater Resistome: Identifying Knowledge Gaps to Inform Future Research Directions
por: Abia, Akebe Luther King, et al.
Publicado: (2023)

Prevalence of pre-extensively drug-resistant tuberculosis (Pre XDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) among extra pulmonary (EP) multidrug resistant tuberculosis (MDR-TB) at a tertiary care center in Mumbai in pre Bedaquiline (BDQ) era
por: Utpat, Ketaki V., et al.
Publicado: (2023)

Enteropathogenic Escherichia coli (EPEC) expressing a non-functional bundle-forming pili (BFP) also leads to increased growth failure and intestinal inflammation in C57BL/6 mice
por: Ledwaba, Solanka Ellen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nasd4ei5sl2o5bvcb65h55rpaf